Omega-3 Fatty Acids and Depression in Lung Cancer Patients
Author Information
Author(s): Kobayakawa M, Yamawaki S, Hamazaki K, Akechi T, Inagaki M, Uchitomi Y
Primary Institution: National Cancer Center Research Institute East
Hypothesis
Lower levels of omega-3 FAs (EPA, DHA) in serum phospholipids are associated with major and minor depression in lung cancer patients.
Conclusion
The levels of DHA and EPA in serum phospholipids were not low in subjects with major and minor depressions in Japanese lung cancer patients.
Supporting Evidence
- The study involved 717 lung cancer patients who were assessed for depression using the HADS.
- DHA levels were significantly higher in the minor depression group compared to the major depression group.
Takeaway
This study looked at whether omega-3 fats in the blood are linked to depression in lung cancer patients, and found that they aren't lower in depressed patients.
Methodology
A three matched group case-control study using the Hospital Anxiety and Depression Scale to classify depression levels and gas chromatography to measure fatty acids.
Potential Biases
Potential bias due to exclusion of patients with cognitive impairment and those on antidepressants.
Limitations
Subjects with severe depression were excluded, and the study lacked healthy control data for comparison.
Participant Demographics
Japanese lung cancer patients, with a majority being male.
Statistical Information
P-Value
0.017
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website